nad+ with tirzepatide What is Therapy: Science-Backed Health Benefits nad+ and tirzepatide Together: Safety

Cintron D, Lipford M, Larrea-Mantilla L, et al

Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline

In a 40-week double blinded, placebo-controlled study, weekly injections of Tirzepatide (15mg) in Type 2 Diabetes Mellitus (T2DM) patients was capable of reducing body weight by an average of 10.1%, over placebo at 40 weeks

The Big Question: How Does Aetna Decide on Coverage

Starting too high causes : Severe nausea and vomiting Extreme fatigue Intolerable side effects Protocol abandonment Gradual titration : Minimizes side effects Allows adaptation Improves tolerance Maintains adherence Standard schedule : Start 2.5mg weekly, increase every 4 weeks until reaching maintenance dose